Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
8.19
-0.51 (-5.86%)
Mar 14, 2025, 1:19 PM EDT - Market open
DAWN Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -95.5 | -188.92 | -142.18 | -70.65 | -40.51 | |
Depreciation & Amortization | 2.03 | 0.38 | 0.53 | 0.2 | 0.16 | |
Asset Writedown & Restructuring Costs | 55 | 3 | - | 8 | - | |
Loss (Gain) From Sale of Investments | -6.39 | -10.08 | -2.03 | - | - | |
Stock-Based Compensation | 48.26 | 39.34 | 27.24 | 13.32 | 0.53 | |
Other Operating Activities | -108 | - | - | -2.11 | 26.69 | |
Change in Accounts Receivable | -13.88 | - | - | - | - | |
Change in Inventory | -3.24 | - | - | - | - | |
Change in Accounts Payable | 0.69 | 2.32 | -1.48 | 1.54 | 0.13 | |
Change in Unearned Revenue | 4.79 | - | - | - | - | |
Change in Other Net Operating Assets | 38.13 | 7.1 | 8.05 | 1.15 | -0.49 | |
Operating Cash Flow | -78.11 | -146.85 | -109.87 | -48.54 | -13.49 | |
Capital Expenditures | -2.17 | -0.22 | -0.03 | - | -0.09 | |
Sale (Purchase) of Intangibles | -72.1 | -3 | - | -8 | - | |
Investment in Securities | -264.73 | 131.6 | -255.05 | - | - | |
Other Investing Activities | 108 | - | - | - | - | |
Investing Cash Flow | -230.99 | 128.38 | -255.07 | -8 | -0.09 | |
Issuance of Common Stock | 182.35 | 164 | 165.9 | 167.36 | - | |
Other Financing Activities | 20.94 | - | - | - | - | |
Financing Cash Flow | 203.29 | 164 | 165.9 | 297.12 | 29.98 | |
Net Cash Flow | -105.82 | 145.52 | -199.05 | 240.58 | 16.4 | |
Free Cash Flow | -80.28 | -147.08 | -109.9 | -48.54 | -13.58 | |
Free Cash Flow Margin | -61.21% | - | - | - | - | |
Free Cash Flow Per Share | -0.86 | -1.84 | -1.68 | -1.31 | -2.46 | |
Cash Income Tax Paid | 1.9 | - | - | - | - | |
Levered Free Cash Flow | -133.99 | -82.72 | -56.86 | -37.01 | -9.6 | |
Unlevered Free Cash Flow | -133.99 | -82.72 | -56.86 | -37.01 | -9.58 | |
Change in Net Working Capital | -22.66 | -9.57 | -7.21 | -2.94 | 1.56 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.